ArticleMedicine2026
The causal relationship between diabetes mellitus and hashimoto thyroiditis: A two-sample mendelian randomization analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study aims to investigate the genetic correlation and potential causal relationship between diabetes mellitus (DM) and Hashimoto thyroiditis (HT), and to assess the effects of type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) on HT risk, with the goal of informing thyroid-function monitoring in patients with DM and improving HT management. We used linkage disequilibrium score regression (LDSC) to estimate the genetic correlation between DM and HT. We then performed two-sample Mendelian randomization (TSMR) using data from genome-wide association studies (GWAS) to evaluate potential causal effects of DM subtypes on HT. We selected single-nucleotide polymorphisms (SNPs) as instrumental variables (IVs) and applied the inverse-variance weighted (IVW) method along with complementary sensitivity analyses to estimate causal effects. We assessed heterogeneity using Cochran's Q test and identified outlier SNPs with MR-PRESSO (Mendelian Randomization Pleiotropy RESidual Sum and Outlier). We used the MR-Egger intercept to test for directional pleiotropy. Finally, we performed a leave-one-out analysis to evaluate whether any single SNP unduly influenced the MR estimates. LDSC showed a significant negative genetic correlation between DM and HT (rG = -0.3285, SE = 0.062, P = 1.20 × 10-7), with evidence of nonzero SNP heritability (h2P < .005). In two-sample MR analyses of DM overall, the IVW estimate suggested increased HT risk in UK Biobank (OR = 7.26, 95% CI = 1.95-27.11, P < .05) and was directionally consistent in FinnGen (OR = 1.08, 95% CI = 1.02-1.14, P < .05). Subtype-specific MR analyses supported a causal effect of T2DM on HT (OR = 1.10, 95% CI = 1.05-1.16, P < .05), whereas there was no evidence for a causal effect of T1DM (OR = 1.04, 95% CI = 0.97-1.12, P > .05). We provide genetic support for a causal relationship between T2DM liability and higher HT risk, with no evidence of a direct causal effect for T1DM. These findings motivate periodic thyroid-function assessment and integrated endocrine-metabolic care in T2DM, and warrant multi-ancestry and mechanistic studies to refine risk prediction and identify actionable biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.